TY  - JOUR
T1  - Lifetime hiv antiretroviral therapy adherence intervention: Timing is everything: comment on “managed problem solving for antiretroviral therapy adherence”
AU  - Bangsberg DR, Haberer JE
Y1  - 2013/02/25
N1  - 10.1001/jamainternmed.2013.2858
JO  - JAMA Internal Medicine
SP  - 306
EP  - 307
VL  - 173
IS  - 4
N2  - 
Modern, potent antiretroviral therapy regimens can suppress human immunodeficiency virus (HIV) replication indefinitely. For those who have access to these drugs and who are able to adhere on a daily basis to these drugs, life expectancy now approaches that of individuals without HIV infection, particularly if they start therapy early.1- 2 Full lifetime viral suppression offers the potentially transformative public health benefit of reducing transmission leading to a decline in number of new HIV infections.3

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.2858
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.2858
ER  -